Diabetes Information [Return To Home Page]

Diabetic Complications - Can Benfotiamine Help Prevent Them?


Diabetic complications contribute too many life threatening diseases globally. The root cause of diabetic complications is elevated glucose levels which contribute to blood vessel damage. Diabetic retinopathy, nephropathy, or neuropathy are caused by damage to small blood vessel in the eyes, nerves and kidneys, etc. The bottom line of this damage is the lowering of the life expectancy of millions of diabetics worldwide.

What Can Be Done About It?

Few therapies are available today that treat diabetic complications. Most healthcare professionals recommend that their patients monitor their blood sugar by taking several blood readings a day to determine the amount of sugar in their blood. Blood sugar readings are generally higher from one to two hours after a meal.

It is suggested by these professionals that keeping blood sugar readings as close to normal as possible will reduce the onset of diabetic complications. Research has shown that there are four, chemical pathways that lead to diabetic complications. Instead of trying to explain these rather difficult chemical pathways, let the reader understand that diabetic complications are mainly caused by excess sugar in the cells, a condition known by the term advanced glycation endproducts (AGE) formation.

The research that was released in 2003 by a team of researchers from the Albert Einstein Collage of Medicine opened the possibilities that it may be possible to actually prevent and/or contain diabetic complications such as retinopathy, neuropathy and heart/circulatory conditions brought about by the presence of advanced glycation endproducts.

What Did This Research Suggest?

The Einstein researchers' work showed that a substance called, "benfotiamine", could reduce the effects of AGE by increasing the amount of an enzyme called transketolase. The research indicated that transketolase was increased by 300% which was enough to make a serious reduction of three of the four chemical pathways that open the door for diabetic complications in terms of vascular damage in diabetics. This vascular damage is directly responsible for the diabetic complications such as neuropathy, retinopathy and heart/circulatory conditions that lead to heart attack and stroke.

Can Benfotaimine Be Considered A Prudent Preventative?

Current research suggests that benfotiamine could possibly reduce the chances of diabetics developing the aforementioned complications. Many healthcare professionals readily recommend patients to add this nutritional supplement to their toolkit in the battle to prevent these insidious conditions that shorten the lives of thousands of diabetics annually.

Where Can I Find More Information About Benfotiamine?

More information about benfotiamine can be found by visiting the web site below and following the links. These links will give the reader a good base to make an informed decision about the use of benfotiamine in the battle against diabetic complications brought about by the presence of advanced glycation endproducts (AGE) which is excess sugar in the blood.

Research:

Hans-Peter Hammes, Xueliang Du, Diane Edelstein, Tetsuya Taguchi, Takeshi Matsumura, Qida Ju, Jihong Lin, Angelika Bierhaus, Peter Nawroth, Dieter Hannak, Michael Neumaier, Regine Bergfeld, Ida Giardino, Michael Brownlee. Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy. Nature Medicine 9, 294 - 299 (01 Mar 2003).

Michael Brownlee. Biochemistry and molecular cell biology of diabetic complications Nature 414, 813 - 820 (13 Dec 2001).

Roya Babaei-Jadidi, Nikolaos Karachalias, Naila Ahmed, Sinan Battah, Paul J. Thornalley. Prevention of incipient diabetic nephropathy by high-dose thiamine and benfotiamine - Complications. Diabetes. (August 2003).

Zach Malott is CEO of Brentwood Health International, a nutritional supplement company involved in distribution and supplying wholesale, retail and end users.

Mr. Malott is available to discuss the research as it applies to benfotiamine in the treatment and prevention of diabetic complications such as neuropathy and retinopathy.

He can be reached at:

Phone: 505.354.0526

Website: http://www.emuhealthproducts.com


MORE RESOURCES:

XOMA 052 Clinical Results Support New Type 2 Diabetes Therapeutic ...
MarketWatch - 4 hours ago
XOMA 052 addresses inflammation as an underlying cause of diabetes by targeting Interleukin-1 beta (IL-1 beta), a master signaling protein which triggers ...
Xoma says antibody lowers blood sugar in diabetics Reuters
Xoma’s Phase I biologic reduces glucose levels Pharma Times (subscription)
XOMA announces interim data from two Phase 1 clinical studies of ... RTT News
all 11 news articles


Biodel's diabetes drug VIAject meets goals
Reuters - 1 hour ago
O: Quote, Profile, Research, Stock Buzz) diabetes drug VIAject is as effective as Eli Lilly and Co's (LLY.N: Quote, Profile, Research, Stock Buzz) Humulin ...


Pre-diabetes screening tests
Los Angeles Times, CA - 6 hours ago
The American Diabetes Assn. recommends that all men and women 45 and older (particularly those who are overweight) be screened every three years for ...
Painless Diabetes Test ABC30.com
all 2 news articles


Bristol, Astra diabetes pill promising in studies
Reuters - 2 hours ago
L: Quote, Profile, Research, Stock Buzz) experimental diabetes drug Onglyza significantly improves blood sugar control when added to older medicines, ...
UPDATE: AstraZeneca Onglyza Effective, Tolerated In Studies CNNMoney.com
all 6 news articles


Oneindia

Reliable Test To Spot Pre-Diabetes Developed
Oneindia, India - 7 hours ago
Lead researcher Gerald Hart says that early stages of the disease, scientifically known as "pre-diabetes", are characterised by increased reaction rates ...


TheMedGuru

Once-Weekly Diabetes Drug Boosts Blood Sugar Control
Washington Post, United States - 10 hours ago
7 (HealthDay News) -- A new once-a-week formulation of the injectable diabetes drug Byetta controls blood sugar even better than the older twice-a-day ...
Weekly jab offers hope for diabetes sufferers Telegraph.co.uk
New weekly treatment for type 2 diabetes works better than twice ... guardian.co.uk
Good News for People with Type 2 Diabetes: New Once-Weekly Jab TheMedGuru
News-Medical.net - Food Consumer
all 36 news articles


BBC News

Weekly diabetes jab hopes raised
BBC News, UK - 3 hours ago
It may be possible to replace twice a day jabs to control type 2 diabetes with a shot given just once a week, research suggests. ...
Weekly diabetes drug provides better blood sugar control, spurs ... The Canadian Press
Constant Blood-Sugar Monitoring Helps Adults Only in Study Bloomberg
New Study Demonstrates Glucose Device Rapidly Alleviates Major ... Newswise (press release)
all 13 news articles


Business to raise funds to combat juvenile diabetes
Lancaster Eagle Gazette, OH - 1 hour ago
By JEFFREY BARRON LANCASTER - Advance Auto Parts store manager Troy Jackson is planning a fun way to fight the serious issue of juvenile diabetes. ...


More than 4000 walk for diabetes cure
Peoria Journal Star, IL - 9 hours ago
Andriella was diganosed with juvenile diabetes last May, and the family formed a group called "Andri's Army" to support her among hundreds of other families ...
Walking for Juvenile Diabetes WEEK-TV
Walking for a Cure Central Illinois Proud
all 4 news articles


Diabetes course offered in October
Marshall News Messenger, TX - 10 hours ago
By Louraisel McDonald The number of people with diabetes has increased by three million in three years to a new high of 24 million, according to the Center ...
Education association members are headed to state competition Marshall News Messenger
Sign up for programs from wildlife to pesticide training Marshall News Messenger
all 3 news articles

Diabetes - Google News






home | site map
© 2006